Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Racotumomab in advanced NSCLC
NCT01460472Phase 3Unknown
- Sponsor
- Recombio
- Start
- Sep 2010
- Primary completion
- Sep 2016
- Modality
- Monoclonal Antibodies, Vaccines & Immunotherapeutics
- Countries
- 7
01
Overview
A Phase 3 trial of racotumomab in non-small cell lung cancer (NSCLC), sponsored by Recombio. Status: unknown.
02
Drugs
racotumomab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01460472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01460472.